Cytokinetics Inc (USD)
CYTK
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range9.49 | 9.97
52-Wk Range5.75 | 14.94
Last Close9.82
Mkt Cap (m)580.96
Dividend yield-
ISINUS23282W6057
Volume655,240
Exchange VenueNAS

Company Profile

Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales17.87
P/CF-
Rev Growth (3 year avg)3.20
EPS Growth (3 year avg)-
Operating Margin % -282.26
Net Margin %-337.41
Return on Equity-156.57
Debt/Equity1.64

Legal Documents

Prospectus
en 08/11/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)3147291061332
Operating Income (m)-34-15-3719-113-89
Net Income (m)-34-15-3816-128-106
Basic EPS-1.24-0.41-0.970.41-2.59-1.95
Avg. Diluted Shares Outstanding (m)273639434954
Balance Sheet
USD201320142015201620172018
Current Assets (m)79131113159274208
Non Current Assets (m)42212214
Total Assets (m)83133115170295211
Current Liabilities (m)272432333222
Total Liabilities (m)------
Total Equity (m)5492699411026
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-8-45537-102-101
Capital Expenditure (m)-1-1-1-2-3-1
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
9.82
Last Price